Bachem Holding AG
SIX:BANB

Watchlist Manager
Bachem Holding AG Logo
Bachem Holding AG
SIX:BANB
Watchlist
Price: 79.05 CHF -1.8%
Updated: Aug 14, 2024
Have any thoughts about
Bachem Holding AG?
Write Note

Intrinsic Value

Bachem Holding AG engages in the provision of peptides and oligonucleotides. [ Read More ]

The intrinsic value of one BANB stock under the Base Case scenario is hidden CHF. Compared to the current market price of 79.05 CHF, Bachem Holding AG is hidden .

Key Points:
BANB Intrinsic Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Backtest
Bachem Holding AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BANB based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

AI Assistant
AI Assistant
Ask me anything about Bachem Holding AG

Provide an overview of the primary business activities
of Bachem Holding AG.

What unique competitive advantages
does Bachem Holding AG hold over its rivals?

What risks and challenges
does Bachem Holding AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bachem Holding AG.

Provide P/S
for Bachem Holding AG.

Provide P/E
for Bachem Holding AG.

Provide P/OCF
for Bachem Holding AG.

Provide P/FCFE
for Bachem Holding AG.

Provide P/B
for Bachem Holding AG.

Provide EV/S
for Bachem Holding AG.

Provide EV/GP
for Bachem Holding AG.

Provide EV/EBITDA
for Bachem Holding AG.

Provide EV/EBIT
for Bachem Holding AG.

Provide EV/OCF
for Bachem Holding AG.

Provide EV/FCFF
for Bachem Holding AG.

Provide EV/IC
for Bachem Holding AG.

Show me price targets
for Bachem Holding AG made by professional analysts.

What are the Revenue projections
for Bachem Holding AG?

How accurate were the past Revenue estimates
for Bachem Holding AG?

What are the Net Income projections
for Bachem Holding AG?

How accurate were the past Net Income estimates
for Bachem Holding AG?

What are the EPS projections
for Bachem Holding AG?

How accurate were the past EPS estimates
for Bachem Holding AG?

What are the EBIT projections
for Bachem Holding AG?

How accurate were the past EBIT estimates
for Bachem Holding AG?

Compare the revenue forecasts
for Bachem Holding AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bachem Holding AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bachem Holding AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bachem Holding AG compared to its peers.

Compare the P/E ratios
of Bachem Holding AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Bachem Holding AG with its peers.

Analyze the financial leverage
of Bachem Holding AG compared to its main competitors.

Show all profitability ratios
for Bachem Holding AG.

Provide ROE
for Bachem Holding AG.

Provide ROA
for Bachem Holding AG.

Provide ROIC
for Bachem Holding AG.

Provide ROCE
for Bachem Holding AG.

Provide Gross Margin
for Bachem Holding AG.

Provide Operating Margin
for Bachem Holding AG.

Provide Net Margin
for Bachem Holding AG.

Provide FCF Margin
for Bachem Holding AG.

Show all solvency ratios
for Bachem Holding AG.

Provide D/E Ratio
for Bachem Holding AG.

Provide D/A Ratio
for Bachem Holding AG.

Provide Interest Coverage Ratio
for Bachem Holding AG.

Provide Altman Z-Score Ratio
for Bachem Holding AG.

Provide Quick Ratio
for Bachem Holding AG.

Provide Current Ratio
for Bachem Holding AG.

Provide Cash Ratio
for Bachem Holding AG.

What is the historical Revenue growth
over the last 5 years for Bachem Holding AG?

What is the historical Net Income growth
over the last 5 years for Bachem Holding AG?

What is the current Free Cash Flow
of Bachem Holding AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bachem Holding AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bachem Holding AG

Current Assets 841.5m
Cash & Short-Term Investments 298.5m
Receivables 183.6m
Other Current Assets 359.4m
Non-Current Assets 841.3m
PP&E 814.6m
Intangibles 14m
Other Non-Current Assets 12.8m
Current Liabilities 164.7m
Accounts Payable 29.1m
Accrued Liabilities 45.8m
Other Current Liabilities 89.9m
Non-Current Liabilities 197.6m
Long-Term Debt 218k
Other Non-Current Liabilities 197.4m
Efficiency

Earnings Waterfall
Bachem Holding AG

Revenue
577.3m CHF
Cost of Revenue
-400.4m CHF
Gross Profit
177m CHF
Operating Expenses
-47.6m CHF
Operating Income
129.4m CHF
Other Expenses
-17.5m CHF
Net Income
111.9m CHF

Free Cash Flow Analysis
Bachem Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BANB Profitability Score
Profitability Due Diligence

Bachem Holding AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
hidden
Profitability
Score

Bachem Holding AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BANB Solvency Score
Solvency Due Diligence

Bachem Holding AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Bachem Holding AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BANB Price Targets Summary
Bachem Holding AG

Wall Street analysts forecast BANB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BANB is 78.69 CHF with a low forecast of 52.52 CHF and a high forecast of 105 CHF.

Lowest
Price Target
52.52 CHF
34% Downside
Average
Price Target
78.69 CHF
0% Downside
Highest
Price Target
105 CHF
33% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BANB?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for BANB is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Unlock
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN
Want to learn more about BANB dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

BANB Price
Bachem Holding AG

1M 1M
-6%
6M 6M
+25%
1Y 1Y
-4%
3Y 3Y
-34%
5Y 5Y
+205%
10Y 10Y
+824%
Annual Price Range
79.05
52w Low
55.15
52w High
91.45
Price Metrics
Average Annual Return 52.92%
Standard Deviation of Annual Returns 88.88%
Max Drawdown -70%
Shares Statistics
Market Capitalization 5.9B CHF
Shares Outstanding 74 973 645
Percentage of Shares Shorted
N/A

Competitive Landscape

Company Profile

Bachem Holding AG Logo
Bachem Holding AG

Country

Switzerland

Industry

Life Sciences Tools & Services

Market Cap

5.9B CHF

Dividend Yield

0.51%

Description

Bachem Holding AG engages in the provision of peptides and oligonucleotides. The company is headquartered in Bubendorf, Basel-Landschaft and currently employs 1,639 full-time employees. The company went IPO on 2001-06-29. The firm focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The firm markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

Contact

BASEL-LANDSCHAFT
Bubendorf
Hauptstrasse 144
+41585952021.0
www.bachem.com

IPO

2001-06-29

Employees

1 639

Officers

CEO, COO & Chairman of Group Executive Board
Mr. Thomas Meier
Chief Financial Officer
Mr. Alain Schaffter
Vice President of Global Accounting
Mr. Michael Suter
Chief Technology Officer
Dr. Gunther Loidl
Chief Information Officer
Mr. Achim Pluckebaum
Head of Group Communications
Dr. Daniel Grotzky
Show More
Chief Human Resources Officer
Viviane Minden
Chief Operating Officer of Bachem Americas, Inc.
Dr. Anne-Kathrin Stoller Ph.D.
Chief Commercial Officer
Dr. Torsten Wohr
VP & Head Global Strategic Alliances
Mr. Boris Corpataux
Show Less

See Also

Discover More
What is the Intrinsic Value of one BANB stock?

The intrinsic value of one BANB stock under the Base Case scenario is hidden CHF.

Is BANB stock undervalued or overvalued?

Compared to the current market price of 79.05 CHF, Bachem Holding AG is hidden .

Back to Top